Bioresorbable Coronary Scaffolds Market Outlook, Dynamics and Strategic Insights by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Bioresorbable Coronary Scaffolds Market covers analysis By Product Type ( Drug Eluting Coronary Scaffolds, Everolimus-eluting Device (Absorb GT1), Novolimus-eluting Device (DESolve), Sirolimus-eluting Device, Paclitaxel-eluting device ); Material ( Polyglycolic acid (PGA) Polymers, Polyglycolide Polymers, Bioresorbable Magnesium ); End User ( Hospitals, Ambulatory Surgical Centers, Coronary Catheterization Labs ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00019588
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Bioresorbable scaffolds (BRS) were developed as an alternative to drug-eluting stents (DES) to facilitate vessel restoration and reduce the risk of future adverse events, but problems regarding safety and effectiveness of first-generation BRS have restricted their clinical use.

MARKET DYNAMICS



The bioresorbable coronary scaffolds market is driving due to the factors such as increasing number of coronary artery diseases, and rising demand for biocompatible coronary stents. However, challenges with respect to selection of scaffold material and long duration for the degradation of material is likely to hamper the growth of the market to a certain extent.

MARKET SCOPE



The "Bioresorbable coronary scaffolds Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioresorbable coronary scaffolds market with detailed market segmentation by product type, material, and end user. The bioresorbable coronary scaffolds market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bioresorbable coronary scaffolds market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The bioresorbable coronary scaffolds market is segmented on the basis of product type, material, and end user. Based on product type, the market is segmented into drug eluting coronary scaffolds, everolimus-eluting device (absorb gt1), novolimus-eluting device (desolve), sirolimus-eluting device, and paclitaxel-eluting device. Based on material, the market is segmented into polyglycolic acid (PGA) polymers, polyglycolide polymers, and bioresorbable magnesium. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and coronary catheterization labs.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bioresorbable coronary scaffolds market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bioresorbable coronary scaffolds market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bioresorbable coronary scaffolds market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the bioresorbable coronary scaffolds market in these regions.

MARKET PLAYERS



The report covers key developments in the bioresorbable coronary scaffolds market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bioresorbable coronary scaffolds market are anticipated to have lucrative growth opportunities in the future with the rising demand for bioresorbable coronary scaffolds in the global market. Below mentioned is the list of few companies engaged in the bioresorbable coronary scaffolds market.

The report also includes the profiles of key players in bioresorbable coronary scaffolds market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Amaranth Medical, Inc.
  •  REVA Medical, Inc.
  •  Abbott Vascular Inc.
  •  Elixir Medical Corporation
  •  BIOTRONIK, Inc.
  •  Medtronic
  •  Boston Scientific Corporation
  •  Lombard Medical
  •  Terumo Corporation
  •  KYOTO MEDICAL

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Bioresorbable Coronary Scaffolds Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • Drug Eluting Coronary Scaffolds
  • Everolimus-eluting Device
  • Novolimus-eluting Device
  • Sirolimus-eluting Device
  • Paclitaxel-eluting device
By Material
  • Polyglycolic acid Polymers
  • Polyglycolide Polymers
  • Bioresorbable Magnesium
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Coronary Catheterization Labs
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amaranth Medical, Inc.
  • REVA Medical, Inc.
  • Abbott Vascular Inc.
  • Elixir Medical Corporation
  • BIOTRONIK, Inc.
  • Medtronic
  • Boston Scientific Corporation
  • Lombard Medical
  • Terumo Corporation
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    bioresorbable-coronary-scaffolds-market-report-deliverables-img1
    bioresorbable-coronary-scaffolds-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Amaranth Medical, Inc.
    2. REVA Medical, Inc.
    3. Abbott Vascular Inc.
    4. Elixir Medical Corporation
    5. BIOTRONIK, Inc.
    6. Medtronic
    7. Boston Scientific Corporation
    8. Lombard Medical
    9. Terumo Corporation
    10. KYOTO MEDICAL
    bioresorbable-coronary-scaffolds-market-cagr